IN8bio Inc (INAB) Stock Price

1.28 ▲ +0.07 (+5.79%)
Open: 1.23 Vol: 83.5K Day's range: 1.18 - 1.30 Aug 21, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
INAB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.28▼ 1.23▲ 1.22▲ 1.19▲ 1.12▲
MA10 1.23▲ 1.23▲ 1.22▲ 1.12▲ 1.25▲
MA20 1.22▲ 1.18▲ 1.18▲ 1.08▲ 1.39▼
MA50 1.18▲ 1.23▲ 1.24▲ 1.26▲ 1.72▼
MA100 1.30▼ 1.33▼ 1.34▼ 1.39▼ 1.28▲
MA200 1.36▼ 1.47▼ 1.47▼ 1.63▼ 1.32▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.007▲ 0.014▲ 0.018▲ 0.040▲ -0.020▼
RSI 57.730▲ 56.378▲ 55.689▲ 60.212▲ 45.332▼
STOCH 81.733▲ 50.926     57.025     81.384▲ 20.987    
WILL %R -29.167     -23.333▲ -21.875▲ -4.762▲ -60.000    
CCI 42.945     87.379     94.779     130.259▲ -56.031    
Latest Filters Detected On INAB
MA $INAB Price Crossed Above MA(50) Set Alert
▲ BREAK $INAB Price Breaks 20 Days High Set Alert
▲ BREAK $INAB Price Breaks 10 Days High Set Alert
IN8bio Inc News
IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
Wednesday, June 03, 2026 05:29 AM
NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers (TCEs) ...
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
Wednesday, May 06, 2026 05:00 AM
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) (“IN8bio” or the “Company”), a clinical-stage biopharmaceutical company developing innovative gamma-delta (“γδ”) T cell therapies ...
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Tuesday, March 03, 2026 04:00 PM
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE)-- IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative γδ T cell therapies for cancer and autoimmune ...
INAB historical stock data
date open high low close volume
21/08/26 1.23 1.30 1.18 1.28 83,499
20/08/26 1.22 1.2547 1.17 1.21 17,238
19/08/26 1.16 1.26 1.155 1.20 78,286
18/08/26 1.135 1.17 1.13 1.14 45,255
17/08/26 1.11 1.14 1.052 1.11 36,798
14/08/26 1.19 1.1998 1.10 1.10 55,927
13/08/26 0.9994 1.19 0.94 1.18 373,167
12/08/26 1.07 1.0749 0.88 0.9985 90,158
11/08/26 1.00 1.05 0.9802 1.05 57,687
10/08/26 0.98 1.0099 0.9579 0.9759 66,196
Quote Details
52wk Low:0.88
52wk High:2.73
Vol:83.5K
Avg Vol(3m):1.1M
1Y Chng:-36.41%
1M Chng:-4.48%
Add to Watch List
More Information
Index US Composite
Market Cap. 11.93M